Lymphotoxin beta Receptor
"Lymphotoxin beta Receptor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the tumor necrosis factor receptor superfamily. It has specificity for LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER and TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14. The receptor plays a role in regulating lymphoid ORGANOGENESIS and the differentiation of certain subsets of NATURAL KILLER T-CELLS. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
| Descriptor ID |
D053259
|
| MeSH Number(s) |
D12.776.543.750.705.852.760.245
|
| Concept/Terms |
Lymphotoxin beta Receptor- Lymphotoxin beta Receptor
- Receptor, Lymphotoxin beta
- beta Receptor, Lymphotoxin
- TNFR Superfamily, Member 3
- Tumor Necrosis Factor Receptor Superfamily, Member 3
- Receptors, Lymphotoxin beta
- Lymphotoxin beta Receptors
- beta Receptors, Lymphotoxin
|
Below are MeSH descriptors whose meaning is more general than "Lymphotoxin beta Receptor".
Below are MeSH descriptors whose meaning is more specific than "Lymphotoxin beta Receptor".
This graph shows the total number of publications written about "Lymphotoxin beta Receptor" by people in this website by year, and whether "Lymphotoxin beta Receptor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphotoxin beta Receptor" by people in Profiles.
-
MKK4 activates non-canonical NF?B signaling by promoting NF?B2-p100 processing. Biochem Biophys Res Commun. 2017 09 16; 491(2):337-342.
-
Contribution of the lymphotoxin beta receptor to liver regeneration. J Immunol. 2005 Jul 15; 175(2):1295-300.
-
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest. 1998 Sep 15; 102(6):1142-51.